Skip to main content
. 2017 Jan 14;8(9):15507–15519. doi: 10.18632/oncotarget.14662

Table 1. Association between miR-27a protein expression and clinicopathological features of patients with BC.

Clinicopathological feature Case miR-27a protein expression P
Age of onset 0.337
 ≤ 55 years old 217 2.056 ± 0.710
 > 55 years old 179 2.126 ± 0.735
Menstruation condition 0.450
 Premenopausal 211 2.062 ± 0.708
 Postmenopausal 185 2.117 ± 0.737
Clinical stages < 0.001
 I stage 38 1.381 ± 0.093
 II stage 235 1.817 ± 0.647
 III stage 123 2.823 ± 0.192
Tumor size < 0.001
 ≤ 2 cm 207 1.862 ± 0.246
 > 2 cm 189 1.921 ± 0.240
Lymph node metastasis < 0.001
 Yes 186 2.808 ± 0.228
 No 210 1.450 ± 0.259
Distant metastasis < 0.001
 Yes 118 2.857 ± 0.065
 No 278 1.761 ± 0.618

Note: miR-27a, microRNA-27a; BC, breast cancer.